A nationwide retrospective study in Turkish children with nephrocalcinosis

Background/aim: Nephrocalcinosis (NC) is defined as calcium deposition in the kidney parenchyma and tubules. This study aims to determine the etiology, risk factors, and follow-up results of patients with NC in Turkey. Materials and methods: Patients diagnosed with NC in the pediatric nephrology Department Units of 19 centers from all geographical regions of Turkey over a 10-year period (2010–2019) were included in the study. The medical records from the centers were reviewed and demographic data, admission complaints, medical history, systemic and genetic disorders, risk factors for NC, treatment details, and presence of NC after one-year follow-up, were recorded retrospectively. Results: The study sample included 195 patients (88 females, 107 males). The mean age at diagnosis was 39.44 ± 47.25 (0.5–208) months; 82/190 patients (43.2%) were diagnosed incidentally; 46/195 patients (23.6%) had an underlying disease; idiopathic hypercalciuria was detected in 75/195 (38.4%) patients. The most common systemic diseases were distal renal tubular acidosis in 11/46 patients (23.9%), primary hyperoxaluria in 9/46 patients (19.6%) and Bartter syndrome in 7/46 patients (15.3%). After one year of follow-up, NC resolved in 56/159 patients (35.2%) and they all did not have an underlying systemic disease. Conclusion: The most common presentation of NC was incidental. Distal renal tubular acidosis and primary hyperoxaluria were the main systemic diseases leading to NC, while hypercalciuria was the most common metabolic risk factor. Nephrocalcinosis was found to remain in most of the patients at a one-year follow-up. It may resolve particularly in patients with no underlying systemic disease.Keywords: Bartter syndrome, hypercalciuria, nephrocalcinosis, renal tubular acidosis

PDF

___

1. Wrong O. Nephrocalcinosis. In: Davison AM, Cameron JS, Grünfeld J, editors. Oxford Textbook of Clinical Nephrology. 3rd ed. Oxford, England, UK: Oxford University Press; 2005. pp.1375.
2. Sayer JA, Carr G, Simmons NL. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clinical Science (London, England: 1979) 2004; 106 (6): 549-561. doi: 10.1042/CS20040048
3. Markowitz GS, Nasr SH, Klein P, Anderson H, Stack JI et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Human Pathology 2004; 35 (6): 675- 684. doi: 10.1016/j.humpath.2003.12.005
4. Asplin JR, Mandel NS, Coe FL. Evidence of calcium phosphate supersaturation in the loop of Henle. American Physiological Society Journal 1996; 270: 604-613. doi: 10.1152/ ajprenal.1996.270.4.F604
5. Arons WL, Christensen WR, Sosman MC. Nephrocalcinosis visible by x-ray associated with chronic glomerulonephritis. Annals of Internal Medicine 1955; 42 (2): 260-282. doi: 10.7326/0003-4819-42-2-260
6. Oliveira B, Kleta R, Bockenhauer D, Walsh SB. Genetic, pathophysiological, and clinical aspects of nephrocalcinosis. American Journal of Physiology - Renal Physiology 2016; 311 (6): 1243-1252. doi: 10.1152/ajprenal.00211.2016
7. Ozkan B, Hatun S, Bereket A. Vitamin D intoxication. Turkish Journal of Pediatrics 2012; 54 (2): 93-98. PMID: 22734293
8. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122 (2): 398-417. doi: 10.1542/peds.2007-1894
9. Muñoz-Torres M, García-Martín A. Primary hyperparathyroidism. Medicina Clinica (Barc) 2018; 150 (6): 226-232. doi: 10.1016/j. medcli.2017.07.020
10. Baştuğ F, Düşünsel R. Pediatric urolithiasis: causative factors, diagnosis and medical management. Nature Reviews Urology 2012; 9 (3): 138-146. doi: 10.1038/nrurol.2012.4
11. Weigert A, Hoppe B. Nephrolithiasis and nephrocalcinosis in childhood-risk factor-related current and future treatment options. Frontiers in Pediatrics 2018; 6: 98. doi: 10.3389/ fped.2018.00098
12. Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. Journal of Urology 2010; 184 (3): 1100-1104. doi: 10.1016/j.juro.2010.05.018
13. Cochat P, Pichault V, Bacchetta J, Dubourg L, Sabot JF et al. Nephrolithiasis related to inborn metabolic diseases. Pediatric Nephrology 2010; 25 (3): 415-424. doi: 10.1007/s00467-008- 1085-6
14. Hoppe B, Duran I, Martin A, Kribs A, Benz-Bohm G et al. Nephrocalcinosis in preterm infants: a single center experience. Pediatric Nephrology 2002; 17 (4): 264-268. doi: 10.1007/ s00467-001-0816-8
15. Jellouli M, Karoui W, Abidi K, Hammi Y, Naija O et al. Nephrocalcinosis in Tunisian children. La Tunisie Médicale. 2016; 94 (4): 167-170
16. Rönnefarth G, Misselwitz J. Nephrocalcinosis in children: a retrospective survey. Members of the Arbeitsgemeinschaft für pädiatrische Nephrologie. Pediatric Nephrology 2000; 14 (10- 11): 1016-1021. doi: 10.1007/s004670050065
17. Bhojani N, Paonessa JE, Hameed TA, Worcester EM, Evan AP et al. Nephrocalcinosis in calcium stone formers who do not have systemic disease. Journal of Urology 2015; 194 (5): 1308- 1312. doi: 10.1016/j.juro.2015.05.074
18. Dickson FJ, Sayer JA. Nephrocalcinosis: a review of monogenic causes and insights they provide into this heterogeneous condition. International Journal of Molecular Sciences 2020; 21 (1): 369. doi: 10.3390/ijms21010369
19. Chang HY, Hsu CH, Tsai JD, Li ST, Hung HY et al. Renal calcification in very low birth weight infants. Pediatrics and Neonatology 2011; 52: 145-149. doi: 10.1016/j. pedneo.2011.03.004
20. Porter E, McKie A, Beattie TJ, McColl JH, Aladangady N et al. Neonatal nephrocalcinosis: long term follow up. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006; 91: 333-336. doi: 10.1136/adc.2006.094755